1. Home
  2. LSTA vs FRSX Comparison

LSTA vs FRSX Comparison

Compare LSTA & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FRSX
  • Stock Information
  • Founded
  • LSTA 1980
  • FRSX N/A
  • Country
  • LSTA United States
  • FRSX Israel
  • Employees
  • LSTA N/A
  • FRSX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • FRSX Technology
  • Exchange
  • LSTA Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • LSTA 31.2M
  • FRSX 31.1M
  • IPO Year
  • LSTA N/A
  • FRSX 2017
  • Fundamental
  • Price
  • LSTA $2.64
  • FRSX $1.00
  • Analyst Decision
  • LSTA Strong Buy
  • FRSX
  • Analyst Count
  • LSTA 1
  • FRSX 0
  • Target Price
  • LSTA $15.00
  • FRSX N/A
  • AVG Volume (30 Days)
  • LSTA 72.4K
  • FRSX 273.9K
  • Earning Date
  • LSTA 02-27-2025
  • FRSX 03-26-2025
  • Dividend Yield
  • LSTA N/A
  • FRSX N/A
  • EPS Growth
  • LSTA N/A
  • FRSX N/A
  • EPS
  • LSTA N/A
  • FRSX N/A
  • Revenue
  • LSTA N/A
  • FRSX $473,000.00
  • Revenue This Year
  • LSTA N/A
  • FRSX N/A
  • Revenue Next Year
  • LSTA N/A
  • FRSX N/A
  • P/E Ratio
  • LSTA N/A
  • FRSX N/A
  • Revenue Growth
  • LSTA N/A
  • FRSX 3.28
  • 52 Week Low
  • LSTA $2.19
  • FRSX $0.57
  • 52 Week High
  • LSTA $4.20
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • FRSX 41.99
  • Support Level
  • LSTA $2.45
  • FRSX $0.95
  • Resistance Level
  • LSTA $2.74
  • FRSX $1.20
  • Average True Range (ATR)
  • LSTA 0.32
  • FRSX 0.11
  • MACD
  • LSTA -0.05
  • FRSX -0.04
  • Stochastic Oscillator
  • LSTA 16.48
  • FRSX 9.44

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: